In patients with metastatic CRC at diagnosis, the relationship of HPN with tumor histological grade and metastatic spread supported “the HPN paradox”, according to which tumors have developed a precise spatiotemporal restriction of HPN overexpression [10]. The gene discussed is HPN; the disease is neoplasm.